Joe's Patent practice focuses on intellectual property patent counseling, portfolio management and strategy assessment. He has previously examined, prosecuted and counseled clients on materials sciences, chemical, and biological applications. His experience includes combinatorial chemistry (chemical diversity technologies including antibody and phage display), and combinatorial material science technologies such as nanomaterials, (e.g., nanometals, nanocomposites and surface coating technologies). He also has substantial prosecution and counseling experience in the pharmaceutical/biopharmaceutical, biotechnology, agriculture and medical device areas, including the use of protein and antibody conjugates for drug delivery.
Joe has prepared and prosecuted both U.S. and foreign patent technologies, working with scientists and in-house counsel to identify patentable subject matters and to secure protection. He has advised pharmaceutical industry and clinical laboratory clients on compliance with the Clinical Laboratory Improvements Acts (CLIA). In addition he has conducted investigations and advised clients on matters related to CLIA noncompliance issues and events. He has also prepared numerous briefs for the U.S. Patent Trademark Office Board of Appeals and successfully managed opposition proceedings in other countries.
Joe has numerous years of laboratory experience prior to becoming an attorney. His research interests included the development of steroidal immunomodulators and evaluation of their mechanisms of their action, and rational based drug design.

Linkedin: https://www.linkedin.com/in/joseph-ricigliano-8bab095/

Hoffmann & Baron, LLP: https://www.hbiplaw.com/